Apollo Cancer Centres (ACC) has introduced India’s first LungLife Screening Program, a pioneering initiative aimed at combating lung cancer—responsible for 5.9% of all cancers and 8.1% of cancer-related deaths in the country. With advanced low-dose computed tomography (LDCT) technology, the program focuses on detecting lung cancer at an early, treatable stage, significantly enhancing survival rates and improving outcomes.
Key Focus of the LungLife Screening Program
- Targeted High-Risk Groups:
- Individuals aged 50–80 years.
- Those with a history of smoking or passive smoking.
- People with a family history of lung cancer.
- Asymptomatic individuals (without visible signs of lung cancer).
- Early Detection with LDCT:
- Advanced imaging technology that minimizes radiation exposure while ensuring diagnostic accuracy.
- Proven to improve survival rates by identifying cancer in early stages.
- Bridging Awareness Gaps:
- Studies reveal that nearly 80% of high-risk individuals remain unaware of screening benefits.
- The program emphasizes communication and education to encourage early interventions.
Expert Insights
- Dr. K. Venkateswara Rao, Sr. Consultant Pulmonology: “Early detection through LDCT technology empowers patients with better survival chances while prioritizing safety and precision.”
- Dr. Rakesh Reddy Boya, Sr. Consultant Medical Oncology: “Our LungLife Program combines innovation with patient-centric care to revolutionize cancer treatment in India.”
- Dr. Pradeep Ventrapati, Consultant Medical Oncology: “By addressing lung cancer early, we significantly enhance recovery prospects and transform lives.”
Leadership Perspectives
- Mr. J. Ramchandra, COO, Apollo Hospitals, Visakhapatnam: “The LungLife Program reflects our leadership in oncology care and commitment to saving lives through proactive health interventions.”
Apollo Cancer Centres: A Legacy of Excellence
With over three decades of experience, Apollo Cancer Centres continues to set benchmarks in oncology with its 360-degree cancer care model. The network includes 390 oncologists delivering precision therapies across India, complemented by advanced facilities like the Pencil Beam Proton Therapy Centre, the first of its kind in South Asia.
As per the press release, The LungLife Screening Program underscores Apollo’s mission to combat cancer with cutting-edge technology, timely detection, and compassionate care, inspiring nationwide action in the fight against lung cancer.